Publication:
Overcoming chemoresistance in triple negative breast cancer by bromodomain inhibition

Simple item page
dc.conference.date27 October 2022
dc.conference.locationBarcelona, Spain
dc.conference.organizer34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
dc.contributor.coauthorPhilpott, M.
dc.contributor.coauthorCribbs, A.
dc.contributor.coauthorOppermann, U.
dc.contributor.departmentSchool of Medicine
dc.contributor.departmentKUTTAM (Koç University Research Center for Translational Medicine)
dc.contributor.facultymemberYes
dc.contributor.kuauthorAksu, Ali Cenk
dc.contributor.kuauthorAyhan, Ceyda Açılan
dc.contributor.kuauthorBayram, Özlem Yedier
dc.contributor.kuauthorCevatemre, Buse
dc.contributor.kuauthorCingöz, Ahmet
dc.contributor.kuauthorDeğirmenci, Nareg Pınarbaşı
dc.contributor.kuauthorEsin, Beril
dc.contributor.kuauthorKayabölen, Alişan
dc.contributor.kuauthorÖnder, Tuğba Bağcı
dc.contributor.kuauthorÖnder, Tamer Tevfik
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.contributor.schoolcollegeinstituteResearch Center
dc.date.accessioned2024-11-09T23:39:18Z
dc.date.issued2022
dc.description.fulltextNo
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.openaccessNO
dc.description.peerreviewstatusN/A
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipScientific and Technological Research Council of Turkey (TUBITAK) [1003- 216S461] This work was supported by The Scientific and Technological Research Council of Turkey (TUBITAK) 1003- 216S461 Grant
dc.description.studentonlypublicationNo
dc.description.studentpublicationYes
dc.description.versionN/A
dc.identifier.WoSQuartileQ1
dc.identifier.doi10.1016/S0959-8049(22)00985-6
dc.identifier.eissn1879-0852
dc.identifier.embargoN/A
dc.identifier.endpageS69
dc.identifier.grantno1003- 216S461
dc.identifier.issn0959-8049
dc.identifier.scopus2-s2.0-85143781807
dc.identifier.startpageS69
dc.identifier.urihttps://doi.org/10.1016/S0959-8049(22)00985-6
dc.identifier.urihttps://hdl.handle.net/20.500.14288/13076
dc.identifier.volume174
dc.identifier.wos000876973400176
dc.keywordsEpigenetics
dc.keywordsBreast cancer
dc.keywordsDrug resistance
dc.language.isoeng
dc.publisherElsevier
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofEuropean Journal of Cancer
dc.relation.openaccessN/A
dc.rightsN/A
dc.subjectOncology
dc.titleOvercoming chemoresistance in triple negative breast cancer by bromodomain inhibition
dc.typeMeeting Abstract
dspace.entity.typePublication
local.contributor.kuauthorBayram, Özlem Yedier
local.contributor.kuauthorCingöz, Ahmet
local.contributor.kuauthorAksu, Ali Cenk
local.contributor.kuauthorDeğirmenci, Nareg Pınarbaşı
local.contributor.kuauthorEsin, Beril
local.contributor.kuauthorKayabölen, Alişan
local.contributor.kuauthorCevatemre, Buse
local.contributor.kuauthorAyhan, Ceyda Açılan
local.contributor.kuauthorÖnder, Tuğba Bağcı
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication91bbe15d-017f-446b-b102-ce755523d939
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublicationd437580f-9309-4ecb-864a-4af58309d287
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files

Collections

Publications without Fulltext